Health experts warned that while McDonald’s expansion into regional Australia in the next two years would bode well for local economies, it would not be good for their population’s health.
About a third of the 100 McDonald’s Australia restaurants set to open in the next two years will be in regional and remote areas.
Cameron Newlands, a senior director of the restaurant group, said population growth and government and private investment in regional areas were driving where they would open.
Newlands said the average McDonald’s restaurant fills about 120 full-time, part-time, and casual jobs across different roles from kitchen, service, and management roles in each town, which is substantial in terms of employment opportunity.
But the move is controversial in towns battling obesity and related diseases.
Megan Belot, the president of the Rural Doctors Association of Australia, said that while it’s nice to think that McDonald’s would provide more jobs and opportunities for our younger people, they don’t need fast food in our smaller rural communities who already have an increased risk of obesity.
Belot said the focus for regional communities should be on better access to more fresh food and vegetables and meat.
Dr. Kim Houghton, the chief economist at the Regional Australia Institute, said McDonald’s may be increasingly drawn to the regions as they weren’t as affected by those capital city lockdowns in 2020 due to Covid and bounced back much faster than the city.
Erica Spry, an Aboriginal research officer for the Kimberley Aboriginal Medical Services, said she was very concerned about the effect of fast-food restaurants on the indigenous population, who are seeing increasing rates of diabetes across multiple generations.
Research by Spry and Julia Marley, professor of health research at the rural clinical school of the University of Western Australia, shows Indigenous populations in rural and remote populations can have three times the average rate of diabetes as the general population.


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Lee Seung-heon Signals Caution on Rate Hikes, Supports Higher Property Taxes to Cool Korea’s Housing Market
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tabletop particle accelerator could transform medicine and materials science
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



